Cite
APA Citation
Wagner, A. J., Agulnik, M., Heinrich, M. C., Mahadevan, D., Riedel, R. F., von Mehren, M., Trent, J., Demetri, G. D., Corless, C. L., Yule, M., Lyons, J. F., Oganesian, A., & Keer, H. (2016). dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. European journal of cancer, 61, 94–101. http://access.bl.uk/ark:/81055/vdc_100039064995.0x00001c